DYNAVAX TECHNOLOGIES CORP — Investor Relations & Filings
Dynavax Technologies Corp. is a commercial-stage biopharmaceutical company focused on developing and commercializing vaccines to prevent infectious diseases. The company's core strength lies in its proprietary Toll-like Receptor (TLR) immune-modulating technology. Its lead commercial product is HEPLISAV-B, an adult hepatitis B vaccine that utilizes the company's CpG 1018 adjuvant to enhance the immune response. In addition to marketing its own vaccines, Dynavax supplies its CpG 1018 adjuvant to other companies for use in their vaccine development programs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-11 | English | |
| 4 Filing | 2026-02-11 | English | |
| 4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer) | 2026-02-10 | English | |
| 4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer) | 2026-02-10 | English | |
| 4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer) | 2026-02-10 | English | |
| 4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer) | 2026-02-10 | English |
Browse filings by year
17 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
DYNAVAX TECHNOLOGIES CORP via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32130/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32130 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32130 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32130 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32130}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DYNAVAX TECHNOLOGIES CORP (id: 32130)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.